Trinity Biotech plc announced that Mr. John Gillard, Group Chief Financial Officer, has informed the Board of Directors of the Company of his intention to resign in order assume a senior finance role in an organisation outside the life sciences sector. Mr. Gillard is expected to leave Trinity Biotech in April 2022 and a process to appoint his successor will now commence.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | -4.01% | -2.81% | -19.35% |
1st Jan change | Capi. | |
---|---|---|
-19.35% | 16.38M | |
-1.74% | 12.65B | |
-6.06% | 8.01B | |
-0.58% | 5.35B | |
+21.79% | 5.23B | |
+2.05% | 4.69B | |
-51.30% | 3.26B | |
+7.80% | 2.64B | |
-7.60% | 2.23B | |
-0.96% | 1.94B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech plc Announces John Gillard, Group Chief Financial Officer Intention to Resign